Navigation Links
WuXi PharmaTech Announces Second-Quarter 2009 Results
Date:8/11/2009

and continue investments."



                          WUXI PHARMATECH (CAYMAN) INC.
                      UNAUDITED CONSOLIDATED BALANCE SHEETS
  (in thousands of U.S. dollars, except ordinary share, ADS and par value data)

                                                        June 30,   December 31,
                                                          2009         2008
    Assets:
    Current assets:
      Cash and cash equivalents                          92,215       56,624
      Restricted cash                                     1,645        1,338
      Short-term investment                              10,246       14,631
      Accounts receivable, net                           45,982       36,457
      Inventories                                         6,632        6,926
      Prepaid expenses and other current assets          10,149        7,281
      Assets of discontinued operations (Note 1, 2)       3,754        6,508
         Total current assets                           170,623      129,765
    Non-current assets:
      Goodwill                                           23,956       23,956
      Property, plant and equipment, net                169,257      152,704
      Intangible assets, net                              8,231        9,934
      Prepaid land use rights                             5,363        5,424
      Deferred tax assets                                 8,836        8,807
      Other non-current assets                            5,965        5,809
         Total non-current assets                       221,608      206,634

         Total assets                                   392,231      336,399

    Liabilities and shareholders' equity:
    Current liabilities:
      Short-term and current portion of long-term debt   47,179        7,558
      Accounts payable                                   23,295       19,829
      Accrued expenses                                   11,
'/>"/>
SOURCE  WuXi PharmaTech (Cayman) Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 

Related biology technology :

1. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2009 Annual General Meeting
2. WuXi PharmaTech Schedules Second-Quarter 2009 Earnings Release
3. WuXi PharmaTech Receives Award from BASF
4. WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise
5. WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U.S. Operations
6. WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services
7. WuXi PharmaTech to Present at Third Annual Jefferies Healthcare Conference
8. WuXi PharmaTech Schedules First-Quarter 2009 Earnings Release
9. Pharmatech Oncology Selected to Present at Company Showcase at BIOZONA
10. WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results
11. The Fitzsimons Redevelopment Authority Selects Pharmatech Oncology as Preferred Vendor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... (PRWEB) June 19, 2013 Express Diagnostics ... tests, today announced that it has received Class III ... and sell its DrugCheck® NxStep Onsite Drug Screen ... of the rapid screening device in near-patient settings, such ... Screen Cup received Health Canada Class III approval for ...
(Date:6/18/2013)... Santa Clara, CA (PRWEB) June 18, 2013 ... compared to standard size SEMs but have limited performance ... and lower resolution. Full size SEMs would normally provide ... require more knowledge to operate and have a higher ... SEMs address the gap between these two types ...
(Date:6/18/2013)... 2013 China Cord Blood Corporation (NYSE: ... provider of cord blood collection, laboratory testing, hematopoietic stem ... its preliminary unaudited financial results for the fourth quarter ... 31, 2013. Fourth Quarter of Fiscal ... of fiscal 2013 increased by 33.3% to RMB133.0 million ...
(Date:6/18/2013)... Angeles, CA (PRWEB) June 18, 2013 (PRWEB) June ... construction’s #1 time and attendance system in North ... software that shares employee data and payroll records ... AccountLinx Plus automates ExakTime software setup ... The software imports employee data from a business’ ...
Breaking Biology Technology:Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3Nanounity Introduces the Pemtron Range of Compact Scanning Electron Microscopes 2Nanounity Introduces the Pemtron Range of Compact Scanning Electron Microscopes 3China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 2China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 3China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 4China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 5China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 6China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 7China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 8China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 9China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 10China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 11China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 12China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 13ExakTime Introduces AccountLinx Plus 2
... , , , ... , With the introduction of the Pwo Master, Roche Applied,Science ... up to,3 kb, providing the highest possible fidelity during PCR,synthesis. , ... , Pwo Master is a premixed double-concentrated formulation,that contains PwoSUPER ...
... , , , ... , , , , ... these reagents significantly influences the results of your experiments. , ... , Roche Applied Science developed a new manufacturing ...
... , , , ... , Now that we know complete,genomes, ... by a,genome at a specific stage.,Assembling the protein puzzle,presents an even ... is the complexity of protein,structure and function, and the sensitivity of ...
Cached Biology Technology:Pwo Master*:,Simplify Setup of Your Proofreading PCRs 2Pwo Master*:,Simplify Setup of Your Proofreading PCRs 3Tools for Proteomic Science II 2Tools for Proteomic Science II 3Tools for Proteomic Science II 4
(Date:6/19/2013)... is the most potent physiological anabolic agent for ... synthesis of lipids, protein and carbohydrates, and inhibiting ... It also plays a major role in stimulating ... is metabolized and removed from the blood following ... molecular mechanisms by which insulin regulates glucose uptake ...
(Date:6/19/2013)... form into the most perfectly spherical large objects in ... in a new study. It appears in ACS, journal ... Langmuir. , Julyan Cartwright, Antonio G. Checa and Marthe ... prized pearls have perhaps the most perfectly spherical, or ... are visible without a microscope. Pearls develop as nacre ...
(Date:6/19/2013)... ITHACA, N.Y. A Cornell University study offers further ... 4 million to 6 million years ago was profoundly ... in turning genes on and off. , The study, ... evidence for a 40-year-old hypothesis that regulation of genes ... is little difference between humans and chimps in the ...
Breaking Biology News(10 mins):Breakthrough research of essential molecule reveals important targets in diabetes and obesity 2New research backs theory that genetic 'switches' play big role in human evolution 2New research backs theory that genetic 'switches' play big role in human evolution 3
... Penn State University have discovered that adding a dash of ... spongy, reusable blocks that have an astounding ability to absorb ... of potential innovations for the material created in a single ... puts kinks and elbows into the nanotubes as they grow ...
... to treating one of the most common types of ... called FLT3, according to new research led by physician-scientists ... Diller Family Comprehensive Cancer Center. Published this week ... certain activating mutations in the FLT3 gene as targets ...
... of researchers led by Boston University School of Medicine ... associated with decreasing the volume of the hippocampus. The ... an important role in the formation of specific, new ... disease lose. The findings may have broad implications in ...
Cached Biology News:Nanosponges soak up oil again and again 2Nanosponges soak up oil again and again 3An Achilles heel of AML 2An Achilles heel of AML 3BUSM researchers identify genes that influence hippocampal volume 2
4',6-Diamidino-2-phenylindole, dihydrochloride (DAPI)...
Includes PROTEAN II xi Basic unit and IPG conversion kit PROTEAN II XL Cell, wide format, Compatible with ReadyStrip IPG Strips 1.0 mm 165-3188 1.5 mm 165-3189 2.0 mm 165-3190...
... cell, 16 cm, is used for vertical slab ... agarose gels. The cell is supplied without spacers ... core with gaskets, lower buffer chamber, lid with ... clamps, upper buffer dam, casting stand with gaskets, ...
... This depletion cocktail is ... (CD3+CD4+CD8+) cells from suspensions of ... Cells are separated using the ... immunomagnetic negative selection system, achieving ...
Biology Products: